Typically, BrafV600E-dependent melanoma can be achieved by deletion or inactivation of known tumor suppressors, such as PTEN [53, 80], p16Ink4A [81–83], Fbxo4 [58]. The gene discussed is CDKN2A; the disease is melanoma.